MICHELLE BRTEK-ZWIENER: Open Payments
NPI 1144299041 · NORFOLK, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,726 in 60 payments from 15 companies in 2025. Trend: 2023 $5,081 · 2024 $6,286 · 2025 $12,726
Speaker / faculty: $7,569Consulting: $1,980Food & beverage: $1,651Travel & lodging: $1,526
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $11,690 |
| RECORDATI_RARE_DISEASES_INC. | 11 | $278 |
| Abbott Laboratories | 4 | $214 |
| Collegium Pharmaceutical, Inc. | 3 | $117 |
| Madrigal Pharmaceuticals | 3 | $72 |
| Corcept Therapeutics | 3 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $62 |
| Lilly USA, LLC | 2 | $42 |
| Mannkind Corporation | 2 | $39 |
| Aimmune Therapeutics, Inc. | 2 | $36 |
Products named: Ozempic, Rybelsus, ISTURISA, FREESTYLE LIBRE 3, Jornay PM, JARDIANCE, REZDIFFRA, Korlym.
Industry payments across NE — which companies pay providers there.
